Sapience Therapeutics Funding: $64M Raised, Series B (2022)
Sapience Therapeutics is based in New York. It has raised $64M in total funding. Latest round: Series B.
Sapience Therapeutics funding overview
Sapience Therapeutics is based in New York. Sapience Therapeutics has raised $64M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in May 2022. The round record for Sapience Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include NexPoint, Bristol Myers Squibb, Eshelman Ventures, Kingdon Capital. 4 distinct backers are named across the disclosed rounds.
Sapience Therapeutics at a glance
Total raised
$64M
Latest round
Series B
Latest round date
May 2022
Headquarters
New York
Notable investors
NexPoint, Bristol Myers Squibb, Eshelman Ventures, Kingdon Capital
Frequently asked about Sapience Therapeutics funding
How much has Sapience Therapeutics raised?
Sapience Therapeutics has raised $64M in total disclosed funding across the rounds on record.
Who has invested in Sapience Therapeutics?
NexPoint, Bristol Myers Squibb, Eshelman Ventures, Kingdon Capital are named among the investors backing Sapience Therapeutics.
What was the latest Sapience Therapeutics funding round?
The most recent disclosed round is a Series B, announced in May 2022.
Where is Sapience Therapeutics based?
Sapience Therapeutics is based in New York.
When did Sapience Therapeutics last raise?
The last disclosed Sapience Therapeutics round closed in May 2022 at Series B.
We update the Sapience Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in New York and their backers are listed below.
